Sfoglia per Autore
The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy
2023-01-01 Galosi, Andrea B.; Milanese, Giulio; Montesi, Lorenzo; Cimadamore, Alessia; Franzese, Carmine; Palagonia, Erika; Chiacchio, Giuseppe; Castellani, Daniele
Vascular Enlargement as a Predictor of Nodal Involvement in Bladder Cancer
2023-01-01 Borgheresi, Alessandra; Agostini, Andrea; Sternardi, Francesca; Cesari, Elisa; Ventura, Fiammetta; Ottaviani, Letizia; Delle Fave, Rocco Francesco; Pretore, Eugenio; Cimadamore, Alessia; Filosa, Alessandra; Galosi, Andrea Benedetto; Giovagnoni, Andrea
Biomarkers of angiogenesis and clinical outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Randomized Phase III METEOR Trial
2022-03-24 Cimadamore, Alessia
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer
2022-01-01 Krajewski, W; Aumatell, J; Subiela, Jd; Nowak, Ł; Tukiendorf, A; Moschini, M; Basile, G; Poletajew, S; Małkiewicz, B; Del Giudice, F; Maggi, M; Chung, Bi; Cimadamore, A; Galosi, Ab; Fave, Rfd; D'Andrea, D; Shariat, Sf; Hornak, J; Babjuk, M; Chorbińska, J; Teoh, Jy; Muilwijk, T; Joniau, S; Tafuri, A; Antonelli, A; Panunzio, A; Alvarez-Maestro, M; Simone, G; Mastroianni, R; Łaszkiewicz, J; Lonati, C; Zamboni, S; Simeone, C; Niedziela, Ł; Candela, L; Macek, P; Contieri, R; Hidalgo, Bg; Rivas, Jg; Sosnowski, R; Mori, K; Mir, C; Soria, F; González-Padilla, Da; Faba, Òr; Palou, J; Ploussard, G; Rajwa, P; Hałoń, A; Laukhtina, E; Pradere, B; Tully, K; Burgos, Fj; Cidre, Máj; Szydełko, T
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity
2022-01-01 Al-Obaidy, K. I.; Saleeb, R. M.; Trpkov, K.; Williamson, S. R.; Sangoi, A. R.; Nassiri, M.; Hes, O.; Montironi, R.; Cimadamore, A.; Acosta, A. M.; Alruwaii, Z. I.; Alkashash, A.; Hassan, O.; Gupta, N.; Osunkoya, A. O.; Sen, J. D.; Baldrige, L. A.; Sakr, W. A.; Idrees, M. T.; Eble, J. N.; Grignon, D. J.; Cheng, L.
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis
2022-01-01 Stangl-Kremser, J.; Muto, G.; Grosso, A. A.; Briganti, A.; Comperat, E.; Maida, F. D.; Montironi, R.; Remzi, M.; Pradere, B.; Soria, F.; Albisinni, S.; Roupret, M.; Shariat, S. F.; Minervini, A.; Teoh, J. Y. -C.; Moschini, M.; Cimadamore, A.; Mari, A.
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?
2022-01-01 Cimadamore, A.; Lonati, C.; Di Trapani, E.; De Cobelli, O.; Rink, M.; Zamboni, S.; Simeone, C.; Soria, F.; Briganti, A.; Montorsi, F.; Afferi, L.; Mattei, A.; Carando, R.; Ornaghi, P. I.; Tafuri, A.; Antonelli, A.; Karnes, R. J.; Colomer, A.; Sanchez-Salas, R.; Contieri, R.; Hurle, R.; Poyet, C.; Simone, G.; D'Andrea, D.; Shariat, S. F.; Galfano, A.; Umari, P.; Francavilla, S.; Roumiguie, M.; Terrone, C.; Hendricksen, K.; Krajewski, W.; Buisan, O.; Laukhtina, E.; Xylinas, E.; Alvarez-Maestro, M.; Roupret, M.; Montironi, R.; Moschini, M.
T1 bladder carcinoma with variant histology: pathological features and clinical significance
2022-01-01 Lopez-Beltran, A.; Blanca, A.; Cimadamore, A.; Montironi, R.; Luque, R. J.; Volavsek, M.; Cheng, L.
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming?
2022-01-01 Marchetti, A.; Rosellini, M.; Nuvola, G.; Tassinari, E.; Mollica, V.; Rizzo, A.; Santoni, M.; Cimadamore, A.; Farolfi, A.; Montironi, R.; Fanti, S.; Massari, F.
Histopathology of Prostate Cancer and its Precursors
2022-01-01 Montironi, Rodolfo; Cimadamore, Alessia; Mazzucchelli, Roberta; Lopez-Beltran, Antonio; Scarpelli, Marina; Cheng, Liang
RE: Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer, by Jones TD and Cheng L, https://doi.org/10.1016/j.urolonc.2020.12.007 (Low grade papillary intra-urothelial neoplasia)
2021-01-01 Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R.
Prostate cancer in 2021: Novelties in prognostic and therapeutic biomarker evaluation
2021-01-01 Cimadamore, A.; Mazzucchelli, R.; Lopez-Beltran, A.; Massari, F.; Santoni, M.; Scarpelli, M.; Cheng, L.; Montironi, R.
Molecular characterization of testicular germ cell tumors using tissue microdissection
2021-01-01 Cheng, L.; Mann, S. A.; Lopez-Beltran, A.; Chovanec, M.; Santoni, M.; Wang, M.; Albany, C.; Adra, N.; Davidson, D. D.; Cimadamore, A.; Montironi, R.; Zhang, S.
TNM staging towards a personalized approach in metastatic urothelial carcinoma: What will the future be like?-a narrative review
2021-01-01 Rizzo, A.; Mollica, V.; Cimadamore, A.; Santoni, M.; Scarpelli, M.; Schiavina, R.; Cheng, L.; Lopez-Beltran, A.; Brunocilla, E.; Montironi, R.; Massari, F.
Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments
2021-01-01 Santoni, M.; Tombesi, F.; Cimadamore, A.; Montironi, R.; Piva, F.
Correlation between high pd-l1 and emt/invasive genes expression and reduced recurrence-free survival in blood-circulating tumor cells from patients with non-muscle-invasive bladder cancer
2021-01-01 Morelli, M. B.; Amantini, C.; de Vermandois, J. A. R.; Gubbiotti, M.; Giannantoni, A.; Mearini, E.; Maggi, F.; Nabissi, M.; Marinelli, O.; Santoni, M.; Cimadamore, A.; Montironi, R.; Santoni, G.
Re: Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl, et al. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. Eur Urol Oncol 2021;4:182-91: Image Analysis, Nuclear Abnormality Index, and Pattern Recognition Analysis
2021-01-01 Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Montironi, R.
INTRADUCTAL CARCINOMA IN LOW- AND INTERMEDIATE-RISK PROSTATE CANCER: PATHOLOGICAL AND CLINICAL RELEVANCE
2021-01-01 Chiacchio, Giuseppe; Dell'Atti, Lucio; Palagonia, Erika; Cicconofri, Andrea; Parlavecchio, Arnaldo; Franzese, Carmine; Pitoni, Lucia; Castellani, Daniele; Cimadamore, Alessia; Montironi, Rodolfo; Milanese, Giulio; Galosi, Andrea Benedetto
Chromophobe Renal Cell Carcinoma Aggressiveness and Immuno-oncology Therapy: How to Distinguish the Good One from the Bad One
2021-01-01 Montironi, R.; Cimadamore, A.; Ohashi, R.; Cheng, L.; Scarpelli, M.; Lopez-Beltran, A.; Moch, H.
Agent-Based Learning Model for the Obesity Paradox in RCC
2021-01-01 Belenchia, M.; Rocchetti, G.; Maestri, S.; Cimadamore, A.; Montironi, R.; Santoni, M.; Merelli, E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy | 1-gen-2023 | Galosi, Andrea B.; Milanese, Giulio; Montesi, Lorenzo; Cimadamore, Alessia; Franzese, Carmine; Palagonia, Erika; Chiacchio, Giuseppe; Castellani, Daniele | |
| Vascular Enlargement as a Predictor of Nodal Involvement in Bladder Cancer | 1-gen-2023 | Borgheresi, Alessandra; Agostini, Andrea; Sternardi, Francesca; Cesari, Elisa; Ventura, Fiammetta; Ottaviani, Letizia; Delle Fave, Rocco Francesco; Pretore, Eugenio; Cimadamore, Alessia; Filosa, Alessandra; Galosi, Andrea Benedetto; Giovagnoni, Andrea | |
| Biomarkers of angiogenesis and clinical outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Randomized Phase III METEOR Trial | 24-mar-2022 | Cimadamore, Alessia | |
| Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high-grade non-muscle-invasive urothelial bladder cancer | 1-gen-2022 | Krajewski, W; Aumatell, J; Subiela, Jd; Nowak, Ł; Tukiendorf, A; Moschini, M; Basile, G; Poletajew, S; Małkiewicz, B; Del Giudice, F; Maggi, M; Chung, Bi; Cimadamore, A; Galosi, Ab; Fave, Rfd; D'Andrea, D; Shariat, Sf; Hornak, J; Babjuk, M; Chorbińska, J; Teoh, Jy; Muilwijk, T; Joniau, S; Tafuri, A; Antonelli, A; Panunzio, A; Alvarez-Maestro, M; Simone, G; Mastroianni, R; Łaszkiewicz, J; Lonati, C; Zamboni, S; Simeone, C; Niedziela, Ł; Candela, L; Macek, P; Contieri, R; Hidalgo, Bg; Rivas, Jg; Sosnowski, R; Mori, K; Mir, C; Soria, F; González-Padilla, Da; Faba, Òr; Palou, J; Ploussard, G; Rajwa, P; Hałoń, A; Laukhtina, E; Pradere, B; Tully, K; Burgos, Fj; Cidre, Máj; Szydełko, T | |
| Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity | 1-gen-2022 | Al-Obaidy, K. I.; Saleeb, R. M.; Trpkov, K.; Williamson, S. R.; Sangoi, A. R.; Nassiri, M.; Hes, O.; Montironi, R.; Cimadamore, A.; Acosta, A. M.; Alruwaii, Z. I.; Alkashash, A.; Hassan, O.; Gupta, N.; Osunkoya, A. O.; Sen, J. D.; Baldrige, L. A.; Sakr, W. A.; Idrees, M. T.; Eble, J. N.; Grignon, D. J.; Cheng, L. | |
| The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis | 1-gen-2022 | Stangl-Kremser, J.; Muto, G.; Grosso, A. A.; Briganti, A.; Comperat, E.; Maida, F. D.; Montironi, R.; Remzi, M.; Pradere, B.; Soria, F.; Albisinni, S.; Roupret, M.; Shariat, S. F.; Minervini, A.; Teoh, J. Y. -C.; Moschini, M.; Cimadamore, A.; Mari, A. | |
| Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy? | 1-gen-2022 | Cimadamore, A.; Lonati, C.; Di Trapani, E.; De Cobelli, O.; Rink, M.; Zamboni, S.; Simeone, C.; Soria, F.; Briganti, A.; Montorsi, F.; Afferi, L.; Mattei, A.; Carando, R.; Ornaghi, P. I.; Tafuri, A.; Antonelli, A.; Karnes, R. J.; Colomer, A.; Sanchez-Salas, R.; Contieri, R.; Hurle, R.; Poyet, C.; Simone, G.; D'Andrea, D.; Shariat, S. F.; Galfano, A.; Umari, P.; Francavilla, S.; Roumiguie, M.; Terrone, C.; Hendricksen, K.; Krajewski, W.; Buisan, O.; Laukhtina, E.; Xylinas, E.; Alvarez-Maestro, M.; Roupret, M.; Montironi, R.; Moschini, M. | |
| T1 bladder carcinoma with variant histology: pathological features and clinical significance | 1-gen-2022 | Lopez-Beltran, A.; Blanca, A.; Cimadamore, A.; Montironi, R.; Luque, R. J.; Volavsek, M.; Cheng, L. | |
| PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What’s Now, What’s New, and What’s Coming? | 1-gen-2022 | Marchetti, A.; Rosellini, M.; Nuvola, G.; Tassinari, E.; Mollica, V.; Rizzo, A.; Santoni, M.; Cimadamore, A.; Farolfi, A.; Montironi, R.; Fanti, S.; Massari, F. | |
| Histopathology of Prostate Cancer and its Precursors | 1-gen-2022 | Montironi, Rodolfo; Cimadamore, Alessia; Mazzucchelli, Roberta; Lopez-Beltran, Antonio; Scarpelli, Marina; Cheng, Liang | |
| RE: Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer, by Jones TD and Cheng L, https://doi.org/10.1016/j.urolonc.2020.12.007 (Low grade papillary intra-urothelial neoplasia) | 1-gen-2021 | Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Montironi, R. | |
| Prostate cancer in 2021: Novelties in prognostic and therapeutic biomarker evaluation | 1-gen-2021 | Cimadamore, A.; Mazzucchelli, R.; Lopez-Beltran, A.; Massari, F.; Santoni, M.; Scarpelli, M.; Cheng, L.; Montironi, R. | |
| Molecular characterization of testicular germ cell tumors using tissue microdissection | 1-gen-2021 | Cheng, L.; Mann, S. A.; Lopez-Beltran, A.; Chovanec, M.; Santoni, M.; Wang, M.; Albany, C.; Adra, N.; Davidson, D. D.; Cimadamore, A.; Montironi, R.; Zhang, S. | |
| TNM staging towards a personalized approach in metastatic urothelial carcinoma: What will the future be like?-a narrative review | 1-gen-2021 | Rizzo, A.; Mollica, V.; Cimadamore, A.; Santoni, M.; Scarpelli, M.; Schiavina, R.; Cheng, L.; Lopez-Beltran, A.; Brunocilla, E.; Montironi, R.; Massari, F. | |
| Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer Environments | 1-gen-2021 | Santoni, M.; Tombesi, F.; Cimadamore, A.; Montironi, R.; Piva, F. | |
| Correlation between high pd-l1 and emt/invasive genes expression and reduced recurrence-free survival in blood-circulating tumor cells from patients with non-muscle-invasive bladder cancer | 1-gen-2021 | Morelli, M. B.; Amantini, C.; de Vermandois, J. A. R.; Gubbiotti, M.; Giannantoni, A.; Mearini, E.; Maggi, F.; Nabissi, M.; Marinelli, O.; Santoni, M.; Cimadamore, A.; Montironi, R.; Santoni, G. | |
| Re: Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl, et al. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. Eur Urol Oncol 2021;4:182-91: Image Analysis, Nuclear Abnormality Index, and Pattern Recognition Analysis | 1-gen-2021 | Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Montironi, R. | |
| INTRADUCTAL CARCINOMA IN LOW- AND INTERMEDIATE-RISK PROSTATE CANCER: PATHOLOGICAL AND CLINICAL RELEVANCE | 1-gen-2021 | Chiacchio, Giuseppe; Dell'Atti, Lucio; Palagonia, Erika; Cicconofri, Andrea; Parlavecchio, Arnaldo; Franzese, Carmine; Pitoni, Lucia; Castellani, Daniele; Cimadamore, Alessia; Montironi, Rodolfo; Milanese, Giulio; Galosi, Andrea Benedetto | |
| Chromophobe Renal Cell Carcinoma Aggressiveness and Immuno-oncology Therapy: How to Distinguish the Good One from the Bad One | 1-gen-2021 | Montironi, R.; Cimadamore, A.; Ohashi, R.; Cheng, L.; Scarpelli, M.; Lopez-Beltran, A.; Moch, H. | |
| Agent-Based Learning Model for the Obesity Paradox in RCC | 1-gen-2021 | Belenchia, M.; Rocchetti, G.; Maestri, S.; Cimadamore, A.; Montironi, R.; Santoni, M.; Merelli, E. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile